Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. - Wikidata - wikimedia - TriplyDB

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.

http://www.wikidata.org/entity/Q33899641

about

What happens to cardiovascular system behind the undetectable level of HIV viremia?Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy.Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected Adults Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review.Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Stu Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.Immune activation and cardiovascular disease in chronic HIV infection.Soluble CD14: An Independent Biomarker for the Risk of Mother-to-Child Transmission of HIV in a Setting of Preexposure and Postexposure Antiretroviral Prophylaxis.The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to Vascular Inflammation in Human Immunodeficiency Virus Infection Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide.Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.Neurologic Complications in Treated HIV-1 Infection.Lipid Abnormalities and Inflammation in HIV Inflection.Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression.Incidental findings on chest computed tomography are common and linked to inflammation in HIV-infected adults.Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy.Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV.

P2860

Q26749024-2CE4466A-F4D6-4A1B-91E4-044D659AE44B Q26774828-58149434-AC53-4D04-8802-AAFFAF4DB3ED Q26851535-4A22E8AC-933C-4401-9A71-0CFF91E55141 Q30248286-B6CE8F5F-FFD5-43FD-9622-3A51E5B6BC06 Q30366554-727F40BE-0189-4AC2-B9AF-18C3564953B0 Q33629231-CC7B958D-D908-46D1-9838-2D46060737DC Q33917580-2C23B487-E971-45A4-ADD2-F8BF16F684FC Q34494208-EBC6F256-E445-4E53-AABD-61DABF3A607F Q34736818-B69FA487-75FF-414E-8122-952396749636 Q35030351-EC1FF1F3-45EA-4109-A513-1BA06A15F32E Q35473503-4C01FF8E-0E09-4B5A-AB71-41C716895561 Q35508766-85B23690-7A15-4D98-8A69-41CE1DA8ABAD Q35861519-41C32CE7-4348-4973-862F-A49433A48A1C Q35935289-13AE5EC0-988E-49CB-961F-154275155302 Q35965242-B0C42977-9B39-4214-B8E6-651DB29C6EB4 Q36078749-0955FF74-5361-46A1-84C5-C039C003DAB6 Q36087826-0C326BFE-8F05-471B-ADD5-D7EE0FEEF84A Q36170370-E89BB4B0-3C63-43F7-8904-A98E09C907BC Q36249027-E38A2608-12E3-45AE-B43A-CBD63B1287B8 Q36341298-DF7723A3-A33D-40FF-80C6-23077468B1EC Q36440262-C76BD151-C8F1-4888-BF0F-19DE22D1BCC6 Q36556082-5ADC5223-FFF3-4558-B1FB-2AD00F181976 Q36562812-5016D206-59EA-4C74-A044-82402C2F84AB Q36601953-06DB9231-4BAB-48F2-BD16-4E6F5C34B8DF Q37003062-365F9709-D765-4C65-9ADE-F859037B256C Q37098390-9E271352-E70D-413A-9D83-6117B0B64FE4 Q37102014-8C7DFB9A-67E4-4AF9-ADED-2CAE4E88C2EA Q37543675-91D21EA3-0F06-4C15-95DD-F0D4C7BCD71E Q37604553-1442280B-1608-4D4B-93A6-7DE202DA7D89 Q38368637-1DC71B90-F06E-42B3-ACE7-5F7E96C7081B Q38614592-17BE1CDD-63F7-430D-9AC5-88207C4D36FE Q38832560-E7A00071-58EB-4FEC-98D0-A7E0EF61BF5C Q38849283-4E914223-6685-4E31-9960-04A351B0CA4E Q38864670-9D33D9EA-3FE5-4531-91C9-85A0FB628348 Q38960712-010662C4-E05C-41EF-B3EB-AC125ADDEDC1 Q38988925-899C8376-60FB-48B4-B6CC-9E0E0E858A59 Q39147832-A2084674-7B0B-4DB1-8EFC-EAF4B21808F7 Q39372824-A8B2F934-C036-4396-91AB-5C927D6C5F93 Q40116631-4364890C-05DE-4510-9EEC-D757E4FCD987 Q40132566-8A5A61B1-28D6-46E7-93EF-32B120ADD31D

P2860

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.

http://www.wikidata.org/entity/Q33899641

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Soluble CD14 is independently ...... ease in treated HIV infection.

@ast

Soluble CD14 is independently ...... ease in treated HIV infection.

@en

type

label

Soluble CD14 is independently ...... ease in treated HIV infection.

@ast

Soluble CD14 is independently ...... ease in treated HIV infection.

@en

prefLabel

Soluble CD14 is independently ...... ease in treated HIV infection.

@ast

Soluble CD14 is independently ...... ease in treated HIV infection.

@en

P1433

Q33899641-16A2FC45-EB93-400E-810D-FE17A3D61F8B

P1476

Q33899641-0E0B42EE-B79C-4AF1-B99D-327F40B3BBB7

P2093

Q33899641-10E7431E-E7BD-4F68-9DEE-14F8EED2DAA4

Q33899641-1D87D0E2-3FD0-415E-91DB-B181EE16D78A

Q33899641-2167EF7A-6291-4746-BCAF-2ECED9D4B3DD

Q33899641-33932791-38F5-4E7B-BE22-D9D092C37555

Q33899641-45A908A6-02E2-4530-89A6-54618DFCE4ED

Q33899641-4A191C78-60CC-43E8-897D-DD2936357B2B

Q33899641-50FDA3CB-2F58-4870-BA3D-B85E2EDF6326

Q33899641-8FC43BBE-B98D-439D-A7FE-25E046957810

Q33899641-DF3AA943-B9C8-416C-A0EF-A27FBBF63ED3

P2860

Q33899641-0A8CC3E6-21FB-4740-91F4-334A4D691AB8

Q33899641-0F931BCA-4595-416E-B805-8319E828E32D

Q33899641-1454A2DC-238F-4D06-9A60-51023937B479

Q33899641-1AAD7418-ED37-441F-912F-00A6FE0A9760

Q33899641-1ACFB9BE-71EC-44E9-8176-240F31BC5545

Q33899641-1C2A1517-FFC1-4442-B188-94A39419B56B

Q33899641-1DD1BDFA-473F-46E5-92C7-444DAB8B984F

Q33899641-1E05D97B-A822-454E-8EAC-8C12B818122B

Q33899641-2573FBA0-4CC7-4B8C-B866-992CD7495217

Q33899641-2D041DB2-7236-42A6-8138-F3BAAED0346F

P304

Q33899641-0D899381-D52D-43AC-92BC-3504E36EB49F

P31

Q33899641-94C7D5E7-FCD7-4205-909F-A5E726635151

P356

Q33899641-556EDF56-D21C-4B74-A352-1DA152E8A591

P407

Q33899641-AC160E60-C24F-47B4-BC6C-DEFF956D071C

P433

Q33899641-0BBECB47-A701-4D16-8C46-FD838576D076

P478

Q33899641-196C7504-D4FA-430B-8F89-4F9119F1076B

P50

Q33899641-CF225B7F-C795-448D-9A0E-C9A621BF0000

P577

Q33899641-4AE27469-A792-4442-A687-95AA4FD0C651

P698

Q33899641-9D65BCAD-F9EC-4DC9-A206-899ABC9B7845

P932

Q33899641-4DDE9260-12A6-45C4-8581-5364C46F5011

P356

QAD.0000000000000158

P1433

P1476

Soluble CD14 is independently ...... ease in treated HIV infection.

@en

P2093

Carl E Orringer

http://www.w3.org/2001/XMLSchema#string

Chris T Longenecker

http://www.w3.org/2001/XMLSchema#string

Danielle E Labbato

http://www.w3.org/2001/XMLSchema#string

Grace A McComsey

http://www.w3.org/2001/XMLSchema#string

Michael M Lederman

http://www.w3.org/2001/XMLSchema#string

Norma Storer

http://www.w3.org/2001/XMLSchema#string

Robert C Gilkeson

http://www.w3.org/2001/XMLSchema#string

Sara Debanne

http://www.w3.org/2001/XMLSchema#string

Ying Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

HIV infection and the risk of acute myocardial infarction.

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation

Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?

Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.

P304

969-977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000000158

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas Funderburg

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24691204

http://www.w3.org/2001/XMLSchema#string

P932

4097603

http://www.w3.org/2001/XMLSchema#string